4//SEC Filing
Tactic Pharma LLC 4
Accession 0001654954-19-014150
CIK 0001645469other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 6:33 PM ET
Size
11.5 KB
Accession
0001654954-19-014150
Insider Transaction Report
Form 4
Tactic Pharma LLC
10% Owner
Transactions
- Purchase
Common stock
2019-12-18$8.00/sh+125,000$1,000,000→ 291,667 total
Holdings
- 4,111,272.88(indirect: See Footnotes (1) and (2))
Common stock
O'Halloran Thomas V.
Other
Transactions
- Purchase
Common stock
2019-12-18$8.00/sh+125,000$1,000,000→ 291,667 total
Holdings
- 4,111,272.88(indirect: See Footnotes (1) and (2))
Common stock
Mazar Andrew Paul
Other
Transactions
- Purchase
Common stock
2019-12-18$8.00/sh+125,000$1,000,000→ 291,667 total
Holdings
- 4,111,272.88(indirect: See Footnotes (1) and (2))
Common stock
Robinson Chandler
DirectorChief Executive Officer
Transactions
- Purchase
Common stock
2019-12-18$8.00/sh+125,000$1,000,000→ 291,667 total
Holdings
- 4,111,272.88(indirect: See Footnotes (1) and (2))
Common stock
BROWN MICHAEL J
Other
Transactions
- Purchase
Common stock
2019-12-18$8.00/sh+125,000$1,000,000→ 291,667 total
Holdings
- 4,111,272.88(indirect: See Footnotes (1) and (2))
Common stock
Footnotes (2)
- [F1]This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein.
- [F2]Tactic has voting and investment power over 4,111,272.88 of the shares of common stock held by TacticGem LLC.
Documents
Issuer
Monopar Therapeutics
CIK 0001645469
Entity typeother
IncorporatedIL
Related Parties
1- filerCIK 0001727357
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 6:33 PM ET
- Size
- 11.5 KB